NCT05417386 2025-11-18
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
Phase 1 Terminated
Massachusetts General Hospital
PhytoHealth Corporation
Brown University
Dana-Farber Cancer Institute
BeiGene
Shandong Cancer Hospital and Institute
Pfizer
Celgene
The University of Texas Health Science Center at San Antonio
National Institutes of Health Clinical Center (CC)
Tata Memorial Hospital
M.D. Anderson Cancer Center